WO2016108064A1 - Foaming dairy compositions - Google Patents
Foaming dairy compositions Download PDFInfo
- Publication number
- WO2016108064A1 WO2016108064A1 PCT/IB2014/003144 IB2014003144W WO2016108064A1 WO 2016108064 A1 WO2016108064 A1 WO 2016108064A1 IB 2014003144 W IB2014003144 W IB 2014003144W WO 2016108064 A1 WO2016108064 A1 WO 2016108064A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- dairy composition
- cmp
- composition
- dairy
- fermented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/1203—Addition of, or treatment with, enzymes or microorganisms other than lactobacteriaceae
- A23C9/1209—Proteolytic or milk coagulating enzymes, e.g. trypsine
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1524—Inert gases, noble gases, oxygen, aerosol gases; Processes for foaming
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1307—Milk products or derivatives; Fruit or vegetable juices; Sugars, sugar alcohols, sweeteners; Oligosaccharides; Organic acids or salts thereof or acidifying agents; Flavours, dyes or pigments; Inert or aerosol gases; Carbonation methods
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/15—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins
- A23C9/1512—Reconstituted or recombined milk products containing neither non-milk fat nor non-milk proteins containing isolated milk or whey proteins, caseinates or cheese; Enrichment of milk products with milk proteins in isolated or concentrated form, e.g. ultrafiltration retentate
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P30/00—Shaping or working of foodstuffs characterised by the process or apparatus
- A23P30/40—Foaming or whipping
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D85/00—Containers, packaging elements or packages, specially adapted for particular articles or materials
- B65D85/70—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for
- B65D85/72—Containers, packaging elements or packages, specially adapted for particular articles or materials for materials not otherwise provided for for edible or potable liquids, semiliquids, or plastic or pasty materials
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
- A23C2210/00—Physical treatment of dairy products
- A23C2210/30—Whipping, foaming, frothing or aerating dairy products
Definitions
- the present invention relates to foaming dairy compositions, in particular foaming fermented dairy compositions, as well as products comprising them, and methods for making the same.
- US Patent No. 4,374, 155 describes a composition containing yogurt which, upon manual shaking, produces a drink containing entrapped air having a milk shake appearance.
- the composition contains yogurt and milk in a yogurtmilk ratio of 80:20 to 53:47, a soya protein whipping agent (i.e. foaming agent) and a stabilizer.
- soya protein whipping agent i.e. foaming agent
- the soya protein whipping agent has not been demonstrated to be a suitable foaming agent for compositions consisting only of yogurt.
- the organoleptic impact of the whipping agent on the obtained composition is not reported.
- Caseinomacropeptide is a glycopeptide which is released in whey from the action of chymosin on milk ⁇ -casein, essentially during the milk-clotting process of cheese-making.
- CMP is glycosylated and is therefore also named caseinoglycomacropeptide (CGMP) or glycomacropeptide (GMP).
- CGMP caseinoglycomacropeptide
- GMP glycomacropeptide
- the present invention arises from the unexpected discovery, by the present inventors, that caseinomacropeptide (CMP) could be used as a foaming agent in fermented dairy compositions. Besides, advantageously and unexpectedly also, foaming fermented dairy compositions prepared with CMP have excellent organoleptic properties and their foaming properties are maintained for at least 28 days after preparation.
- CMP caseinomacropeptide
- the present invention relates to a product comprising:
- dairy composition having a volume Vd, which is comprised in the sealed container, characterized in that the dairy composition comprises caseinomacropeptide (CMP) and 0.6 ⁇ Vd / Vc ⁇ 0.72.
- CMP caseinomacropeptide
- the present invention also relates to a process of preparing a product as defined above, comprising the steps of introducing the dairy composition in the container and then sealing the container.
- the present invention also relates to a method of using the product as defined above, comprising:
- the present invention also relates to a fermented dairy composition which comprises CMP.
- the present invention also relates to a method of preparation of a fermented dairy composition from a dairy composition, comprising the steps of:
- CMP is added to the dairy composition.
- the present invention also relates to the use of CMP as a foaming agent in fermented dairy compositions.
- Figure 1 represents an embodiment of the product according to the invention.
- the product comprises a container (1 ) having a volume Vc, sealed by a sealing (6), and a dairy composition (2), having a volume Vd, which is comprised in the sealed container.
- the container of the represented embodiment of the product according to the invention comprises a flat base (3) on which the container is intended to stand and the largest dimension of the flat base (4) is smaller than the largest dimension of the container which is orthogonal to the flat base (5).
- Vhs represents the volume of the head-space, i.e. the part of the container not occupied by the dairy composition.
- Vhs Vc - Vd.
- a "dairy composition” relates to a milk-based composition suitable for animal consumption, in particular human consumption.
- the dairy composition according to the invention comprises or derives (in particular by fermentation) from a composition containing from 30 to 100% (w/w) milk, more preferably from 50 to 100% (w/w) milk and even more preferably from 70 to 100% (w/w) milk.
- the expression “x% (w/w)” is considered equivalent to "x g per 100 g”.
- the dairy composition according to the invention comprises or derives (in particular by fermentation) from a composition essentially consisting of milk or consisting only of milk.
- milk preferably relates to vegetable or animal milk, more preferably to goat, ewe, or cow milk and most preferably to cow milk.
- the dairy composition according to the invention is a fermented dairy composition, more preferably a fermented milk and most preferably a yogurt.
- a “fermented dairy composition” is derived from a dairy composition according to the invention by the acidifying action of at least one lactic acid bacterium, which may be comprised in a ferment, a culture or a starter.
- the lactic acid bacterium according to the invention preferably belongs to an
- Aerococcaceae Carnobacteriaceae, Enterococcaceae, Lactobacillaceae, Leuconostocaceae, Streptococcaceae or Bifidobacteriaceae family and more preferably to an Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, Weissella or Bifidobacterium genus.
- the lactic acid bacterium according to the invention belongs to a Lactobacillus brevis, Lactobacillus buchneri, Lactobacillus casei, Lactobacillus curvatus, Lactobacillus delbruckei, in particular L. delbruckei supsb.
- Lactobacillus diolivorans Lactobacillus fermentum, Lactobacillus fructivorans, Lactobacillus helveticus, Lactobacillus hilgardii, Lactobacillus jensenii, Lactobacillus kunkeei, Lactobacillus mall, Lactobacillus nagelii, Lactobacillus paracasei, enstock L. paracasei subsp.
- Lactobacillus plantarum Lactobacillus vini, Lactobacillus rhamnosus, Streptococcus thermophilus, Streptococcus lactis, Streptococcus raffinolactis, Streptococcus cremoris, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium lactis, or Bifidobacterium longum species.
- One or more lactic acid bacteria can be used for obtaining a fermented dairy composition according to the invention.
- an association of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus is used for obtaining a fermented dairy composition according to the invention. This latter association is often referred to as a yogurt ferment or symbiosis.
- the lactic acid bacterium is a probiotic bacteria.
- the same decree reserves the denomination "yogurt" to a fermented milk obtained by the development of the sole specific thermophilic lactic acid bacteria named Lactobacillus bulgaricus (also named Lactobacillus delbruckei subsp. bulgaricus) and Streptococcus thermophilus, which shall be sown together and be found alive in the finished product, in an amount of at least 10 million bacteria per gram in respect of the milky part.
- the quantity of free lactic acid that the yogurt contains shall not be below 0.7 g per 100 g at the time of selling.
- the dairy composition in particular the fermented dairy composition, according to the invention, may comprise secondary ingredients such as fruits, vegetables, sugars, flavors, starch, thickeners, or stabilizers.
- secondary ingredients such as fruits, vegetables, sugars, flavors, starch, thickeners, or stabilizers.
- fermented milks may be added with the following products: aromatic extracts, natural aromas, as well as, in the limit of 30% in weight of finished product, sugars and other alimentary ingredients which yield a specific flavor.
- the dairy composition in particular the fermented dairy composition, according to the invention comprises at least one foaming agent in addition to CMP.
- the dairy composition, in particular the fermented dairy composition, according to the invention does not comprise any other foaming agent in addition to CMP.
- the dairy composition according to the invention has a pH equal to or lower than 5, more preferably between 3.5 and 4.5.
- the composition has a viscosity of lower than 200 mPa.s, more preferably lower than 100 mPa.s and most preferably lower that 60 mPa.s, at 10°C, at a shear rate of 64 s '
- the dairy composition according to the invention is a drink fermented dairy composition, more preferably a drink fermented milk and most preferably a drink yogurt.
- the dairy composition in particular the fermented dairy product, according to the invention, or the product according to the invention, is stored at a temperature of from 1 °C to 10°C.
- caseinomacropeptide is considered a synonym of glycomacropeptide (GMP) or caseinoglycomacropeptide (CGMP).
- CMP is well known by one of skill in the art. CMP is usually released in whey from the action of chymosin on milk ⁇ -casein, essentially during the milk-clotting process of cheese-making. Thus CMP essentially consists of amino-acids 106-169 of milk ⁇ -casein. It is preferred that CMP originates from cow, ewe or goat milk, in particular from cow milk.
- the dairy composition in particular the fermented dairy composition, according to the invention, comprises CMP.
- CMP is preferably added or incorporated to the dairy composition, in particular the fermented dairy composition, according to the invention, in the form of (i) a whey preparation, such as whey powder, a whey protein preparation, in particular a whey protein isolate (WPI), a whey protein hydrolysate (WPH) or a whey protein concentrate (WPC), or combinations thereof, or of (ii) a preparation isolated, concentrated or purified therefrom.
- Commercial CMP preparations which can be added or incorporated to dairy compositions, in particular fermented dairy compositions, according to the invention, notably encompass Lacprodan® DI-9224, Lacprodan® CGMP-10 or Lacprodan® CGM P-20, all from Aria Food Ingredients.
- the dairy composition in particular the fermented dairy composition, according to the invention, comprises CM P at a concentration of at least 0.3, 0.5, 0.75, 1 , 2, 5 or 10% (w/w).
- the dairy composition in particular the fermented dairy composition according to the invention, comprises CMP at a concentration of 20, 10, 5 or 2% (w/w) at the most.
- CMP is a foaming agent, i.e. CMP imparts increased foaming properties to the dairy composition, in particular the fermented dairy composition, according to the invention, which comprises it.
- increased foaming properties are considered equivalent to “an increased capacity to incorporate air” or to “increased foam expansion”.
- the "increase” in foaming properties of a dairy composition, in particular a fermented dairy composition, according to the invention, which comprises CMP is relative to the same composition without added CMP under the same conditions of determination of the foaming properties.
- a “foaming agent” is considered equivalent to a “whipping agent”. It is understood that foaming agents increase the interface between air and a liquid or fluid composition which comprises them, thereby facilitating the incorporation of air in the composition upon shaking or agitation thereof.
- the foaming properties of a dairy composition, in particular a fermented dairy composition, according to the invention can be determined by measuring the volume Vi of a unshaken sample of a dairy composition, in particular a fermented dairy composition, according to the invention, shaking the sample, and measuring the volume Vf of the shaken sample.
- the formula (Vf - Vi) / Vi then yields a value of the foaming properties of the dairy composition, in particular a fermented dairy composition, according to the invention.
- the shaking step of the method of determination of the foaming properties of a dairy composition it is preferred that it is implemented by performing 2 up-down movements over a distance of 30-35 cm per second during 20 seconds.
- the dairy compositions, in particular the fermented dairy compositions, according to the invention preferably have foaming properties of from 10% to 50%, more preferably of from 20% to 40% and most preferably of from 30% to 35%.
- the Vd / Vc ratio according to the invention is specifically adapted to the foaming properties of the dairy composition, in particular the fermented dairy composition, according to the invention.
- the head-space of the product according to the invention that is the part of the container not occupied by the dairy composition, in particular the fermented dairy composition, according to the invention, has a volume Vhs sufficient to accommodate the increase in volume of the dairy composition, in particular the fermented dairy composition, according to the invention, due to its foaming upon shaking of the product according to the invention.
- Vhs sufficient to accommodate the increase in volume of the dairy composition, in particular the fermented dairy composition, according to the invention, due to its foaming upon shaking of the product according to the invention.
- 0.65 ⁇ Vd / Vc ⁇ 0.70 0.28 ⁇ Vhs /Vc ⁇ 0.40 and in particular that 0.30 ⁇ Vhs /Vc ⁇ 0.35.
- the fermented dairy composition according to the invention can be prepared from a dairy composition by a method comprising the steps of:
- CMP is added to the dairy composition.
- CMP can be added to the dairy composition at any step of the method, either before, during or after the fermenting step.
- CMP can be added with the slurry, which may further comprise sugars, such as sucrose, and any other secondary ingredient as previously defined.
- CM P is added to the dairy composition prior to the fermenting step, in particular before the heat treating step.
- the heat treating step aims at killing microorganisms which may be present in the dairy composition. Preferably, it at least amounts to a pasteurization.
- CMP is added in amounts such that the fermented dairy composition yielded by the method of preparation according to the invention preferably comprises CM P at a concentration of at least 0.3, 0.5, 0.75, 1 , 2, 5 or 10% (w/w).
- the dairy composition in particular the fermented dairy composition according to the invention, comprises CM P at a concentration of 20, 10, 5 or 2% (w/w) at the most.
- the container and the sealing of the product are made of any material suitable for contacting and stocking dairy products, in particular fermented dairy products according to the invention, intended for animal or human consumption.
- the sealing of the container is preferably tight, i.e. it does not leak when the product according to the invention is shaken. Besides, the sealing can be removed or an aperture can be made into it, to yield access to the dairy composition, in particular the fermented dairy composition, according to the invention.
- the container according to the invention comprises a flat base on which the container is intended to stand and the largest dimension of the flat base is smaller than the largest dimension of the container which is orthogonal to the flat base. In other words, the container is higher than larger.
- 11 is a concentrate or an isolate of native whey proteins extracted directly from milk, and not from whey.
- I2 is a whey protein isolate.
- I3 and I4 are compositions concentrated in CMP processed from whey.
- composition of the ingredients is shown in the following Table 1 :
- Potassium (mg/100g powder) 400 1300 100 2000.0
- Whey proteins (g/1 OOg powder) 1 89.9% 72.2% 28.8% 3.8% Whey proteins do not comprise CGMP
- Example 1 two-step preparation of foaming fermented dairy products 1.1.
- a dairy mix with the following composition is prepared:
- the mix is let to hydrate for 60 min. before being submitted to a heat treatment at 95°C during 5 min and to homogenization at a pressure of 200 bar.
- Yogurt ferments (Streptococcus thermophilus + Lactobacillus delbrueckii subsp. bulgaricus) are then added to the homogenized mix at a concentration of 0.02% (w/w) and fermentation is conducted at 42°C during 5 hours.
- the fermented dairy mix is stirred at a pH of 4.43 and further smoothed by filtration.
- the slurries are incorporated in the fermented dairy mix in a slurry/fermented mix ratio (w/w) of 10/90 or 20/80 and mixed together in a round flask before being smoothed with a mixer (65 Hz, Ystral, Germany).
- the foaming properties i.e. the volume of incorporated air
- 6 mL (Vi) of the fermented dairy compositions incorporating the slurries are poured into 10 ml_- graduated cylinders which are sealed and vigorously agitated (2 up-down movements over a distance of 30-35 cm per second during 20 seconds).
- Vf volume of the agitated fermented dairy compositions incorporating the slurries is measured.
- the volume of incorporated air is then calculated as 100 x (Vf-Vi)/Vi.
- Example 2 one-step preparation of foaming fermented dairy products
- the mix is let to hydrate for 90 min. before being submitted to a heat treatment at 95°C during 5 min and to homogenization at a pressure of 200 bar.
- Yogurt ferments (Streptococcus thermophilus + Lactobacillus delbrueckii subsp. bulgaricus) are then added to the homogenized mix at a concentration of 0.02% (w/w) and fermentation is conducted at 42°C during 5 hours.
- the fermented dairy mix is stirred at a pH of 4.43 and further smoothed by filtration.
- the foaming properties i.e.
- the volume of incorporated air) of the fermented dairy compositions are then determined on the day (DO) the stirred and smoothed fermented dairy mix is obtained, and 14 (D14) and 28 (D28) days after.
- 6 ml_ (Vi) of the fermented dairy compositions incorporating the slurries are poured into 10 ml_- graduated cylinders which are sealed and vigorously agitated (2 up-down movements over a distance of 30-35 cm per second during 20 seconds). The cylinder are then rested for 30 seconds before the volume (Vf) of the agitated fermented dairy compositions incorporating the slurries is measured.
- the volume of incorporated air is then calculated as 100 x (Vf-Vi)/Vi.
- the foaming properties of CMP when directly incorporated in the dairy mix prior to heat treatment and fermentation are even increased with respect to the case when CMP is brought after the fermentation step together with the slurry (Example 1 ), while it could be expected that CMP would preferentially localize at the water-oil interface rather that at the water-air interface in case of direct incorporation in the unfermented initial dairy mix.
- the foaming properties are essentially constant over a period of at least 28 days after the fermented dairy composition has been prepared.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Mechanical Engineering (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dairy Products (AREA)
- Packages (AREA)
- Packging For Living Organisms, Food Or Medicinal Products That Are Sensitive To Environmental Conditiond (AREA)
Abstract
The present invention relates to a product comprising: • - a container (1) having a volume Vc, sealed by a sealing (6), and • - a dairy composition (2), having a volume Vd, which is comprised in the sealed container, characterized in that the dairy composition comprises caseinomacropeptide (CMP) and 0.6 ≤ Vd /Vc ≤ 0.72. The dairy composition is preferably a fermented dairy composition. Preferably the dairy composition or fermented dairy composition comprises CMP at a concentration of at least 0,3%. Further claimed is a fermented dairy composition comprising CMP as well as the use of CMP as a foaming agent in fermented dairy compositions.
Description
FOAMING DAIRY COMPOSITIONS
Field of the invention
The present invention relates to foaming dairy compositions, in particular foaming fermented dairy compositions, as well as products comprising them, and methods for making the same.
Technical background
Relatively few foaming fermented dairy compositions intended for human consumption have been described to date, in spite of their clear commercial potential.
Thus, Krasaekoopt & Bhatia (2012) AU Journal of Technology 15: 166-171 describe the production of yogurt foam using methylcellulose and egg albumin as foaming agents. However, the yogurt foam thus produced is intended for yogurt powder production and is not intended for human consumption as such. Besides, when yogurt powder was used to prepare a drinking yogurt, orange flavor was added, thereby making difficult to assess the organoleptic impact of the foaming agents used on the drinking yogurt, which was "moderately liked" by a testing panel.
In addition, US Patent No. 4,374, 155 describes a composition containing yogurt which, upon manual shaking, produces a drink containing entrapped air having a milk shake appearance. The composition contains yogurt and milk in a yogurtmilk ratio of 80:20 to 53:47, a soya protein whipping agent (i.e. foaming agent) and a stabilizer. However, the soya protein whipping agent has not been demonstrated to be a suitable foaming agent for compositions consisting only of yogurt. Besides, the organoleptic impact of the whipping agent on the obtained composition is not reported.
Accordingly, there is a need for alternative foaming agents, which could be used in fermented dairy compositions and which would not be detrimental to their organoleptic properties.
Caseinomacropeptide (CMP) is a glycopeptide which is released in whey from the action of chymosin on milk κ-casein, essentially during the milk-clotting process of cheese-making. CMP is glycosylated and is therefore also named caseinoglycomacropeptide (CGMP) or glycomacropeptide (GMP). In this regard, there is a significant difference in the non-peptide part of CMP from species such as cow, ewe or goat. In contrast, the amino acid composition of CMP from these species is very similar.
Summary of the invention
The present invention arises from the unexpected discovery, by the present inventors, that caseinomacropeptide (CMP) could be used as a foaming agent in fermented dairy compositions. Besides, advantageously and unexpectedly also, foaming fermented dairy compositions prepared with CMP have excellent organoleptic properties and their foaming properties are maintained for at least 28 days after preparation.
Thus, the present invention relates to a product comprising:
- a container having a volume Vc, sealed by a sealing, and
- a dairy composition, having a volume Vd, which is comprised in the sealed container, characterized in that the dairy composition comprises caseinomacropeptide (CMP) and 0.6≤Vd / Vc≤ 0.72.
The present invention also relates to a process of preparing a product as defined above, comprising the steps of introducing the dairy composition in the container and then sealing the container.
The present invention also relates to a method of using the product as defined above, comprising:
a) shaking the product, to foam the dairy composition,
b) removing the sealing or making an aperture in the sealing of the container, c) transferring the foamed dairy composition to a human mouth.
The present invention also relates to a fermented dairy composition which comprises CMP.
The present invention also relates to a method of preparation of a fermented dairy composition from a dairy composition, comprising the steps of:
- optionally heat treating the dairy composition;
- fermenting the dairy composition by at least one lactic acid bacteria;
- optionally adding a slurry to the fermented dairy composition;
wherein CMP is added to the dairy composition.
The present invention also relates to the use of CMP as a foaming agent in fermented dairy compositions.
Brief description of the figure
Figure 1 represents an embodiment of the product according to the invention. The product comprises a container (1 ) having a volume Vc, sealed by a sealing (6), and a dairy composition (2), having a volume Vd, which is comprised in the sealed
container. The container of the represented embodiment of the product according to the invention comprises a flat base (3) on which the container is intended to stand and the largest dimension of the flat base (4) is smaller than the largest dimension of the container which is orthogonal to the flat base (5). Vhs, represents the volume of the head-space, i.e. the part of the container not occupied by the dairy composition. Vhs = Vc - Vd.
Detailed description of the invention
As intended herein, a "dairy composition" relates to a milk-based composition suitable for animal consumption, in particular human consumption. Preferably, the dairy composition according to the invention comprises or derives (in particular by fermentation) from a composition containing from 30 to 100% (w/w) milk, more preferably from 50 to 100% (w/w) milk and even more preferably from 70 to 100% (w/w) milk. As intended herein, the expression "x% (w/w)" is considered equivalent to "x g per 100 g". Preferably also, the dairy composition according to the invention comprises or derives (in particular by fermentation) from a composition essentially consisting of milk or consisting only of milk. As intended herein "milk" preferably relates to vegetable or animal milk, more preferably to goat, ewe, or cow milk and most preferably to cow milk.
Preferably, the dairy composition according to the invention is a fermented dairy composition, more preferably a fermented milk and most preferably a yogurt.
As intended herein, a "fermented dairy composition" is derived from a dairy composition according to the invention by the acidifying action of at least one lactic acid bacterium, which may be comprised in a ferment, a culture or a starter.
The lactic acid bacterium according to the invention preferably belongs to an
Aerococcaceae, Carnobacteriaceae, Enterococcaceae, Lactobacillaceae, Leuconostocaceae, Streptococcaceae or Bifidobacteriaceae family and more preferably to an Aerococcus, Carnobacterium, Enterococcus, Lactobacillus, Lactococcus, Leuconostoc, Oenococcus, Pediococcus, Streptococcus, Tetragenococcus, Vagococcus, Weissella or Bifidobacterium genus. More preferably, the lactic acid bacterium according to the invention belongs to a Lactobacillus brevis, Lactobacillus buchneri, Lactobacillus casei, Lactobacillus curvatus, Lactobacillus delbruckei, in particular L. delbruckei supsb. bulgaricus or lactis, Lactobacillus diolivorans, Lactobacillus fermentum, Lactobacillus fructivorans, Lactobacillus helveticus, Lactobacillus hilgardii, Lactobacillus jensenii, Lactobacillus kunkeei,
Lactobacillus mall, Lactobacillus nagelii, Lactobacillus paracasei, en particulier L. paracasei subsp. paracasei, Lactobacillus plantarum, Lactobacillus vini, Lactobacillus rhamnosus, Streptococcus thermophilus, Streptococcus lactis, Streptococcus raffinolactis, Streptococcus cremoris, Bifidobacterium adolescentis, Bifidobacterium animalis, Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium lactis, or Bifidobacterium longum species.
One or more lactic acid bacteria can be used for obtaining a fermented dairy composition according to the invention. Thus, in a preferred embodiment, an association of Streptococcus thermophilus and Lactobacillus delbrueckii subsp. bulgaricus is used for obtaining a fermented dairy composition according to the invention. This latter association is often referred to as a yogurt ferment or symbiosis.
In a preferred embodiment, the lactic acid bacterium is a probiotic bacteria.
The expressions "fermented milk" and "yogurt" have the usual meanings attributed to them in the dairy industry.
By way of example, French decree n°88-1203 of December 30th 1988 (revised on
December 26th, 2012) reserves the denomination "fermented milk" to a dairy product prepared with skimmed or non-skimmed milks or with skimmed or non-skimmed concentrated or powdered milks, possibly enriched in milk constituents, having undergone a heat treatment at least equivalent to pasteurization, sown with microorganisms belonging to the characteristic species of each product. The coagulation of the fermented milks shall not be obtained by other means than those which result from the activity of the microorganisms used. The quantity a free lactic acid that the fermented milks contain shall not be below 0.6 g per 100 g at the time of selling and the protein content in respect of the milky part shall not be below that of normal milk.
The same decree reserves the denomination "yogurt" to a fermented milk obtained by the development of the sole specific thermophilic lactic acid bacteria named Lactobacillus bulgaricus (also named Lactobacillus delbruckei subsp. bulgaricus) and Streptococcus thermophilus, which shall be sown together and be found alive in the finished product, in an amount of at least 10 million bacteria per gram in respect of the milky part. The quantity of free lactic acid that the yogurt contains shall not be below 0.7 g per 100 g at the time of selling.
The dairy composition, in particular the fermented dairy composition, according to the invention, may comprise secondary ingredients such as fruits, vegetables, sugars, flavors, starch, thickeners, or stabilizers.
In particular, the above-mentioned decree also provides that fermented milks may be added with the following products: aromatic extracts, natural aromas, as well as, in the limit of 30% in weight of finished product, sugars and other alimentary ingredients which yield a specific flavor.
In a particular embodiment, the dairy composition, in particular the fermented dairy composition, according to the invention comprises at least one foaming agent in addition to CMP. In another particular embodiment, the dairy composition, in particular the fermented dairy composition, according to the invention does not comprise any other foaming agent in addition to CMP.
Preferably, the dairy composition according to the invention has a pH equal to or lower than 5, more preferably between 3.5 and 4.5.
Preferably, the composition has a viscosity of lower than 200 mPa.s, more preferably lower than 100 mPa.s and most preferably lower that 60 mPa.s, at 10°C, at a shear rate of 64 s' Preferably also, the dairy composition according to the invention is a drink fermented dairy composition, more preferably a drink fermented milk and most preferably a drink yogurt.
Preferably also, the dairy composition, in particular the fermented dairy product, according to the invention, or the product according to the invention, is stored at a temperature of from 1 °C to 10°C.
As intended herein, caseinomacropeptide (CMP) is considered a synonym of glycomacropeptide (GMP) or caseinoglycomacropeptide (CGMP). CMP is well known by one of skill in the art. CMP is usually released in whey from the action of chymosin on milk κ-casein, essentially during the milk-clotting process of cheese-making. Thus CMP essentially consists of amino-acids 106-169 of milk κ-casein. It is preferred that CMP originates from cow, ewe or goat milk, in particular from cow milk.
The dairy composition, in particular the fermented dairy composition, according to the invention, comprises CMP.
CMP is preferably added or incorporated to the dairy composition, in particular the fermented dairy composition, according to the invention, in the form of (i) a whey preparation, such as whey powder, a whey protein preparation, in particular a whey protein isolate (WPI), a whey protein hydrolysate (WPH) or a whey protein concentrate (WPC), or combinations thereof, or of (ii) a preparation isolated, concentrated or purified therefrom. Commercial CMP preparations which can be added or incorporated to dairy compositions, in particular fermented dairy compositions, according to the
invention, notably encompass Lacprodan® DI-9224, Lacprodan® CGMP-10 or Lacprodan® CGM P-20, all from Aria Food Ingredients.
Preferably, the dairy composition, in particular the fermented dairy composition, according to the invention, comprises CM P at a concentration of at least 0.3, 0.5, 0.75, 1 , 2, 5 or 10% (w/w). Preferably also, the dairy composition, in particular the fermented dairy composition according to the invention, comprises CMP at a concentration of 20, 10, 5 or 2% (w/w) at the most.
According to the present invention CMP is a foaming agent, i.e. CMP imparts increased foaming properties to the dairy composition, in particular the fermented dairy composition, according to the invention, which comprises it. As intended herein "increased foaming properties" are considered equivalent to "an increased capacity to incorporate air" or to "increased foam expansion". As will be clear to one of skill in the art the "increase" in foaming properties of a dairy composition, in particular a fermented dairy composition, according to the invention, which comprises CMP, is relative to the same composition without added CMP under the same conditions of determination of the foaming properties. As intended herein a "foaming agent" is considered equivalent to a "whipping agent". It is understood that foaming agents increase the interface between air and a liquid or fluid composition which comprises them, thereby facilitating the incorporation of air in the composition upon shaking or agitation thereof.
The foaming properties of a dairy composition, in particular a fermented dairy composition, according to the invention can be determined by measuring the volume Vi of a unshaken sample of a dairy composition, in particular a fermented dairy composition, according to the invention, shaking the sample, and measuring the volume Vf of the shaken sample. The formula (Vf - Vi) / Vi then yields a value of the foaming properties of the dairy composition, in particular a fermented dairy composition, according to the invention. In order to standardize the shaking step of the method of determination of the foaming properties of a dairy composition, it is preferred that it is implemented by performing 2 up-down movements over a distance of 30-35 cm per second during 20 seconds. Using this method of determination of foaming properties, the dairy compositions, in particular the fermented dairy compositions, according to the invention, preferably have foaming properties of from 10% to 50%, more preferably of from 20% to 40% and most preferably of from 30% to 35%.
The Vd / Vc ratio according to the invention is specifically adapted to the foaming properties of the dairy composition, in particular the fermented dairy composition, according to the invention. In other words, the head-space of the product according to
the invention, that is the part of the container not occupied by the dairy composition, in particular the fermented dairy composition, according to the invention, has a volume Vhs sufficient to accommodate the increase in volume of the dairy composition, in particular the fermented dairy composition, according to the invention, due to its foaming upon shaking of the product according to the invention. Preferably, 0.65≤ Vd / Vc≤ 0.70. Symmetrically, it is preferred that 0.28≤ Vhs /Vc≤ 0.40 and in particular that 0.30≤ Vhs /Vc≤ 0.35.
The fermented dairy composition according to the invention can be prepared from a dairy composition by a method comprising the steps of:
- optionally heat treating the dairy composition;
- fermenting the dairy composition by at least one lactic acid bacteria;
- optionally adding a slurry to the fermented dairy composition;
wherein CMP is added to the dairy composition.
As intended in the method of preparation according to the invention, CMP can be added to the dairy composition at any step of the method, either before, during or after the fermenting step. In this regard, CMP can be added with the slurry, which may further comprise sugars, such as sucrose, and any other secondary ingredient as previously defined. However, it is preferred that CM P is added to the dairy composition prior to the fermenting step, in particular before the heat treating step. As will be clear to one of skill in the art, the heat treating step aims at killing microorganisms which may be present in the dairy composition. Preferably, it at least amounts to a pasteurization.
Besides, CMP is added in amounts such that the fermented dairy composition yielded by the method of preparation according to the invention preferably comprises CM P at a concentration of at least 0.3, 0.5, 0.75, 1 , 2, 5 or 10% (w/w). Preferably also, the dairy composition, in particular the fermented dairy composition according to the invention, comprises CM P at a concentration of 20, 10, 5 or 2% (w/w) at the most.
The container and the sealing of the product are made of any material suitable for contacting and stocking dairy products, in particular fermented dairy products according to the invention, intended for animal or human consumption. The sealing of the container is preferably tight, i.e. it does not leak when the product according to the invention is shaken. Besides, the sealing can be removed or an aperture can be made into it, to yield access to the dairy composition, in particular the fermented dairy composition, according to the invention. Preferably, the container according to the invention comprises a flat base on which the container is intended to stand and the
largest dimension of the flat base is smaller than the largest dimension of the container which is orthogonal to the flat base. In other words, the container is higher than larger.
Examples
Ingredients
Four ingredients (11 , I2, I3 and I4), with varying content in CMP, have been used. 11 is a concentrate or an isolate of native whey proteins extracted directly from milk, and not from whey. I2 is a whey protein isolate. I3 and I4 are compositions concentrated in CMP processed from whey.
The composition of the ingredients is shown in the following Table 1 :
Ingredient 11 I2 I3 I4
Prolacta® 90 Lacprodan® Lacprodan® Lacprodan®
References (Lactalis) DI-9224 CGMP-10 CGMP-20
(Provider) (Aria Food (Aria Food (Aria Food
Ingredients) Ingredients) Ingredients)
Powder protein content
90 85 82,5 77 (g/100g powder, NT x 6.38)
Dry matter protein content
95 90 85 81 (g/100g dry matter, NT x 6.38)
Moisture (g/100g powder) 6 5.0 5.0 5.5
NPN x 6,38 (g/100g powder) 0.1 0.1 0.1 0.1
Fat (g/1 OOg powder) 0.4 0.2 0.5 1 .0
Ash (g/1 OOg powder) 3 5 6.5 9.0
Lactose (g/1 OOg powder) 3.0 0.2 2.0 1 .0
Calcium (mg/100g powder) 300 100 1700 100
Chloride (mg/100g powder) 180 50 50 <100
Potassium (mg/100g powder) 400 1300 100 2000.0
Phosphorus (mg/100g powder) 200 200 500 500
Sodium (mg/100g powder) 100 500 400 1500
CMP (g/1 OOg protein) 0 15% 65% 95%
CMP (g/1 OOg powder) 0% 12.7% 53.6% 73.1 %
Whey proteins (g/1 OOg powder)1 89.9% 72.2% 28.8% 3.8% Whey proteins do not comprise CGMP
Table 1 : constitution of the ingredients
Example 1 : two-step preparation of foaming fermented dairy products 1.1. A dairy mix with the following composition is prepared:
Ingredients g/100g mix
Non-fat cow milk
73.98%
powder
Cream 3.66%
Sucrose 1 .25%
Water 21 .12%
Table 2: dairy mix composition
The mix is let to hydrate for 60 min. before being submitted to a heat treatment at 95°C during 5 min and to homogenization at a pressure of 200 bar. Yogurt ferments (Streptococcus thermophilus + Lactobacillus delbrueckii subsp. bulgaricus) are then added to the homogenized mix at a concentration of 0.02% (w/w) and fermentation is conducted at 42°C during 5 hours. The fermented dairy mix is stirred at a pH of 4.43 and further smoothed by filtration.
1.2. Slurries with varying concentrations of CMP are prepared by mixing ingredients 11 , I2, I3, or I4 with sucrose and water under gentle agitation during 90 min.
Control slurry (g/100g)
Sucrose 40.0%
Water 60.0%
Table 3: control slurry composition
Slurry 1
13 6.1%
Saccharose 40.0%
Eau 53.9%
Table 4: control slurry composition
Slurry 2
I4 6,5%
Saccharose 40.0%
Eau 53.5%
Table 5: control slurry composition
Slurry 3
II 5.6%
Saccharose 40.0%
Eau 54.4% Table 6: control slurry composition
Slurry 4
2 5.9%
Saccharose 40.0%
Eau 54.1%
Table 7: control slurry composition
1.3. The slurries are incorporated in the fermented dairy mix in a slurry/fermented mix ratio (w/w) of 10/90 or 20/80 and mixed together in a round flask before being smoothed with a mixer (65 Hz, Ystral, Germany). The foaming properties (i.e. the volume of incorporated air) of the fermented dairy compositions incorporating the slurries are then determined. Briefly, 6 mL (Vi) of the fermented dairy compositions incorporating the slurries are poured into 10 ml_- graduated cylinders which are sealed and vigorously agitated (2 up-down movements over a distance of 30-35 cm per second during 20 seconds). The cylinder are then rested for 30 seconds before the volume (Vf) of the agitated fermented dairy compositions incorporating the slurries is measured. The volume of incorporated air is then calculated as 100 x (Vf-Vi)/Vi.
Whey proteins
Volume of
Slurry amount CMP (%, w/w originating from the
incorporated (g/lOOg final mix) in final mix) slurry (%, w/w in final
air (%) mix)
10% - - 5%
Control slurry
Slurry 1 10% 0.33% 0.18% 11%
Slurry 2 10% 0.48% 0.03% 15%
Slurry 3 10% 0.00% 0.50% 3%
Slurry 4 10% 0.08% 0.43% 7%
Slurry 1 20% 0.65% 0.35% 28%
Slurry 2 20% 0.95% 0.05% 32%
Slurry 3 20% 0.00% 1.00% 5%
Table 8: Foaming properties of the fermented dairy compositions incorporating the slurries It can be seen that concentrations of CMP of as little as 0.08% (g/100g of final mix) endow the fermented dairy product comprising CMP at such concentrations with increased foaming properties, while native whey proteins (which do not comprise CMP) have essentially no foaming properties. Concentrations of CMP of 0.3% (g/100g of final mix) and above increased by a factor of at least 2 the foaming properties of fermented dairy product comprising CMP at such concentrations.
Example 2: one-step preparation of foaming fermented dairy products
Two dairy mixes directly incorporating sucrose and various amounts of CMP are prepared with the following composition:
Ingredients g/100g mix
Non-fat cow milk
64.50%
powder
Cream 2.91 %
Sucrose 5%
Water 26.59%
I3 1.00%
Table 9: dairy mix composition 1 % I3
Ingredients g/100g mix
Non-fat cow milk
70.74%
powder
Cream 2.90%
Sucrose 5%
Water 20.60%
I3 0.75% Table 10: dairy mix composition 0.75% I3
The mix is let to hydrate for 90 min. before being submitted to a heat treatment at 95°C during 5 min and to homogenization at a pressure of 200 bar. Yogurt ferments (Streptococcus thermophilus + Lactobacillus delbrueckii subsp. bulgaricus) are then added to the homogenized mix at a concentration of 0.02% (w/w) and fermentation is conducted at 42°C during 5 hours. The fermented dairy mix is stirred at a pH of 4.43 and further smoothed by filtration. The foaming properties (i.e. the volume of incorporated air) of the fermented dairy compositions are then determined on the day (DO) the stirred and smoothed fermented dairy mix is obtained, and 14 (D14) and 28 (D28) days after. Briefly, 6 ml_ (Vi) of the fermented dairy compositions incorporating the slurries are poured into 10 ml_-
graduated cylinders which are sealed and vigorously agitated (2 up-down movements over a distance of 30-35 cm per second during 20 seconds). The cylinder are then rested for 30 seconds before the volume (Vf) of the agitated fermented dairy compositions incorporating the slurries is measured. The volume of incorporated air is then calculated as 100 x (Vf-Vi)/Vi.
Table 1 1 : Foaming properties of the fermented dairy compositions directly incorporating CMP
Surprisingly, the foaming properties of CMP when directly incorporated in the dairy mix prior to heat treatment and fermentation are even increased with respect to the case when CMP is brought after the fermentation step together with the slurry (Example 1 ), while it could be expected that CMP would preferentially localize at the water-oil interface rather that at the water-air interface in case of direct incorporation in the unfermented initial dairy mix. Advantageously and unexpectedly, the foaming properties are essentially constant over a period of at least 28 days after the fermented dairy composition has been prepared.
Claims
1. A product comprising:
- a container (1) having a volume Vc, sealed by a sealing (6), and
- a dairy composition (2), having a volume Vd, which is comprised in the sealed container,
characterized in that the dairy composition comprises caseinomacropeptide (CMP) and 0.60≤ Vd / Vc≤ 0.72.
2. The product according to claim 1 , wherein 0.65≤ Vd / Vc≤ 0.70.
3. The product according to claim 1 or 2, wherein the container comprises a flat base (3) on which the container is intended to stand and the largest dimension of the flat base (4) is smaller than the largest dimension of the container which is orthogonal to the flat base (5).
4. The product according to any of claims 1 to 3, being stored at a temperature of from 1 °C to 10°C.
5. A product according to any of claims 1 to 4, wherein the dairy composition has a viscosity of lower than 200 mPa.s at 10°C, at a shear rate of 64 s'
6. The product according to any of claims 1 to 5, wherein the dairy composition has a pH equal to or lower than 5, preferably between 3.5 and 4.5.
7. The product according to any of claims 1 to 6, wherein the dairy composition comprises CMP at a concentration of at least 0.3 % (w/w).
8. The product according to any of claims 1 to 7, wherein CMP has been added to the dairy composition in the form of a whey protein preparation.
9. The product according to any of claims 1 to 8, wherein the dairy composition is a fermented dairy composition.
10. A method of using the product according to any of claims 1 to 9, comprising:
a) shaking the product, to foam the dairy composition (2),
b) removing the sealing (6) or making an aperture in the sealing (6) of the container (1 ), c) transferring the foamed dairy composition to a human mouth.
1 1. A fermented dairy composition which comprises CMP.
12. The fermented dairy composition according to claim 1 1 , wherein the dairy composition comprises CM P at a concentration of at least 0.3 % (w/w).
13. A method of preparation of a fermented dairy composition from a dairy composition, comprising the steps of:
- optionally heat treating the dairy composition;
- fermenting the dairy composition by at least one lactic acid bacteria;
- optionally adding a slurry to the fermented dairy composition;
wherein CM P is added to the dairy composition.
14. The method of preparation according to claim 13, wherein CMP is added to the dairy composition prior to the fermenting step, optionally before the heat treating step.
15. The use of CMP as a foaming agent in fermented dairy compositions.
Priority Applications (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/003144 WO2016108064A1 (en) | 2014-12-31 | 2014-12-31 | Foaming dairy compositions |
| MA041283A MA41283A (en) | 2014-12-31 | 2015-12-30 | FOAMING DAIRY COMPOSITIONS |
| PCT/EP2015/081467 WO2016107926A1 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
| US15/540,844 US10537117B2 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
| CA2972546A CA2972546C (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
| BR112017013881-6A BR112017013881B1 (en) | 2014-12-31 | 2015-12-31 | PRODUCT |
| RU2017126050A RU2724553C2 (en) | 2014-12-31 | 2015-12-31 | Foamed milk composition |
| CN201580072040.XA CN107205407A (en) | 2014-12-31 | 2015-12-31 | Foam dairy compositions |
| ES15820192T ES3041375T3 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
| EP15820192.1A EP3240428B1 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
| MX2017008714A MX381831B (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IB2014/003144 WO2016108064A1 (en) | 2014-12-31 | 2014-12-31 | Foaming dairy compositions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2016108064A1 true WO2016108064A1 (en) | 2016-07-07 |
Family
ID=53175541
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IB2014/003144 Ceased WO2016108064A1 (en) | 2014-12-31 | 2014-12-31 | Foaming dairy compositions |
| PCT/EP2015/081467 Ceased WO2016107926A1 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP2015/081467 Ceased WO2016107926A1 (en) | 2014-12-31 | 2015-12-31 | Foaming dairy compositions |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10537117B2 (en) |
| EP (1) | EP3240428B1 (en) |
| CN (1) | CN107205407A (en) |
| BR (1) | BR112017013881B1 (en) |
| CA (1) | CA2972546C (en) |
| ES (1) | ES3041375T3 (en) |
| MA (1) | MA41283A (en) |
| MX (1) | MX381831B (en) |
| RU (1) | RU2724553C2 (en) |
| WO (2) | WO2016108064A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11925188B2 (en) * | 2018-06-20 | 2024-03-12 | General Mills, Inc. | Cultured dairy products and method of preparation |
| CN112075497A (en) * | 2019-06-13 | 2020-12-15 | 天益健康科学研究院(镇江)有限公司 | Compound probiotic yogurt starter |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374155A (en) | 1981-03-02 | 1983-02-15 | Merck & Co. Inc. | Yogurt milk shake |
| DE19906379A1 (en) * | 1999-02-16 | 2000-08-17 | Manfred Hus | Production of concentrate of denatured whey protein hydrolysate with fine aggregate size, useful as food additive, e.g. in cheese or ice cream, uses high temperature hold in aqueous solution without shear before concentration |
| WO2000049885A1 (en) * | 1999-02-25 | 2000-08-31 | Societe Des Produits Nestle S.A. | Milk protein hydrolysate for addressing a bone or dental disorder |
| WO2003070009A1 (en) * | 2002-02-15 | 2003-08-28 | Compagnie Gervais Danone | Novel method for the production of fermented milk products |
| WO2007095969A1 (en) * | 2006-02-22 | 2007-08-30 | Compagnie Gervais Danone | Process for manufacturing a fermented milk |
| WO2010123351A1 (en) * | 2009-04-20 | 2010-10-28 | Friesland Brands B.V. | Satiety inducing milk product |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20070003681A1 (en) * | 2005-06-30 | 2007-01-04 | Kraft Foods Holdings, Inc. | Stable aerated food products containing oil and cyclodextrin |
| WO2011010368A1 (en) * | 2009-07-21 | 2011-01-27 | 三栄源エフ・エフ・アイ株式会社 | Method for enhancing the bubble retention ability of drink |
| CN103891887A (en) * | 2012-12-31 | 2014-07-02 | 内蒙古蒙牛乳业(集团)股份有限公司 | Double-layer dairy product and preparation method thereof |
| RS57403B2 (en) * | 2013-10-23 | 2023-04-28 | Arla Foods Amba | Caseinomacropeptide-containing, high protein denatured whey protein compositions, products containing them, and uses thereof |
| NZ719414A (en) * | 2013-10-23 | 2021-10-29 | Arla Foods Amba | High protein denatured whey protein composition, related products, method of production and uses thereof |
| WO2016066788A1 (en) * | 2014-10-30 | 2016-05-06 | Nestec S.A. | Packaged ambient dairy beverage |
-
2014
- 2014-12-31 WO PCT/IB2014/003144 patent/WO2016108064A1/en not_active Ceased
-
2015
- 2015-12-30 MA MA041283A patent/MA41283A/en unknown
- 2015-12-31 RU RU2017126050A patent/RU2724553C2/en active
- 2015-12-31 WO PCT/EP2015/081467 patent/WO2016107926A1/en not_active Ceased
- 2015-12-31 MX MX2017008714A patent/MX381831B/en unknown
- 2015-12-31 BR BR112017013881-6A patent/BR112017013881B1/en active IP Right Grant
- 2015-12-31 CA CA2972546A patent/CA2972546C/en active Active
- 2015-12-31 CN CN201580072040.XA patent/CN107205407A/en active Pending
- 2015-12-31 ES ES15820192T patent/ES3041375T3/en active Active
- 2015-12-31 EP EP15820192.1A patent/EP3240428B1/en active Active
- 2015-12-31 US US15/540,844 patent/US10537117B2/en active Active
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4374155A (en) | 1981-03-02 | 1983-02-15 | Merck & Co. Inc. | Yogurt milk shake |
| DE19906379A1 (en) * | 1999-02-16 | 2000-08-17 | Manfred Hus | Production of concentrate of denatured whey protein hydrolysate with fine aggregate size, useful as food additive, e.g. in cheese or ice cream, uses high temperature hold in aqueous solution without shear before concentration |
| WO2000049885A1 (en) * | 1999-02-25 | 2000-08-31 | Societe Des Produits Nestle S.A. | Milk protein hydrolysate for addressing a bone or dental disorder |
| WO2003070009A1 (en) * | 2002-02-15 | 2003-08-28 | Compagnie Gervais Danone | Novel method for the production of fermented milk products |
| WO2007095969A1 (en) * | 2006-02-22 | 2007-08-30 | Compagnie Gervais Danone | Process for manufacturing a fermented milk |
| WO2010123351A1 (en) * | 2009-04-20 | 2010-10-28 | Friesland Brands B.V. | Satiety inducing milk product |
Non-Patent Citations (4)
| Title |
|---|
| ANONYMOUS: "BECHER :: JOGHURT :: FOLIE :: JOGHURTBECHER :: DRUCK :: IML :: KÄRNTEN :: SPITTAL/DRAU", 17 November 2013 (2013-11-17), pages 1 - 1, XP055203009, Retrieved from the Internet <URL:http://archive-at-2013.com/open-archive/3173024/2013-11-17/http://www.volpini.at/en/produkte/trockenoffset/75mm_125g.html> [retrieved on 20150716] * |
| KRASAEKOOPT; BHATIA, AU JOURNAL OF TECHNOLOGY, vol. 15, 2012, pages 166 - 171 |
| MARSHALL S C: "CASEIN MACROPEPTIDE FROM WHEY - A NEW PRODUCT OPPORTUNITY", CSIRO FOOD RESEARCH QUARTERLY, MELBOURNE, AU, vol. 51, no. 1/02, 1991, pages 86 - 91, XP002044765, ISSN: 0310-9070 * |
| NEELIMA ET AL: "Chemical and functional properties of glycomacropeptide (GMP) and its role in the detection of cheese whey adulteration in milk: A review", DAIRY SCIENCE AND TECHNOLOGY - PAPERS SELECTED FROM THE EIGHTH CHEESE SYMPOSIUM, 28-29 SEPTEMBER 2011 (FIRST TWO PAPERS) 2013 SPRINGER-VERLAG FRANCE FRA, vol. 93, no. 1, 2013, pages 21 - 43, XP002742387, DOI: 10.1007/S13594-012-0095-0 * |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2017126050A3 (en) | 2019-10-29 |
| MA41283A (en) | 2017-11-07 |
| EP3240428C0 (en) | 2025-08-13 |
| CA2972546A1 (en) | 2016-07-07 |
| BR112017013881A2 (en) | 2018-03-13 |
| US20170354161A1 (en) | 2017-12-14 |
| EP3240428B1 (en) | 2025-08-13 |
| MX381831B (en) | 2025-03-13 |
| EP3240428A1 (en) | 2017-11-08 |
| US10537117B2 (en) | 2020-01-21 |
| CA2972546C (en) | 2022-11-29 |
| BR112017013881B1 (en) | 2022-10-18 |
| RU2724553C2 (en) | 2020-06-23 |
| WO2016107926A1 (en) | 2016-07-07 |
| RU2017126050A (en) | 2019-01-31 |
| CN107205407A (en) | 2017-09-26 |
| ES3041375T3 (en) | 2025-11-11 |
| MX2017008714A (en) | 2018-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2984466C (en) | Manufacture of strained fermented dairy products | |
| JP2009136158A (en) | Production method of cheese-like fermented soybean food | |
| CN106234582A (en) | A kind of utilize Lactose enzyme Yoghourt improving structural state and preparation method thereof | |
| EP3541961B1 (en) | Streptococcus thermophilus for use in preparation of fermented products | |
| CN103188952B (en) | Improve the method for probio survival rate | |
| US11166473B2 (en) | Lactobacillus rhamnosus for use in preparation of fermented products | |
| CN116249766A (en) | Lactic acid bacteria strains with improved texturizing properties | |
| JP7249737B2 (en) | Method for producing fermented milk | |
| Mayo et al. | Fermented milk products | |
| CA2972546C (en) | Foaming dairy compositions | |
| WO2013017905A1 (en) | Composition comprising gellan gum, buttermilk and lactic acid bacteria process of making the same | |
| JP2008295348A (en) | Soy fermented food | |
| Champagne | Development of fermented milk products containing probiotics | |
| US20200359640A1 (en) | Methods for producing fermented milk and lactic acid bacteria starter | |
| EP3442348B1 (en) | Lactobacillus rhamnosus for use in preparation of fermented products | |
| RU2774771C2 (en) | Fermented dairy compositions and methods of preparing the same | |
| CN121729147A (en) | Fermented foods and their manufacturing methods, as well as methods for improving the survival of Bifidobacteria. | |
| EP4277985A1 (en) | Lactic acid bacterial strains with improved texturizing properties | |
| EA041084B1 (en) | THERMOPHILIC STREPTOCOCCI FOR USE IN THE PREPARATION OF FERMENTED PRODUCTS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14863044 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14863044 Country of ref document: EP Kind code of ref document: A1 |
